NCT07021560

Wearability of and Myopia Progression With ZEISS MyoCare Spectacle Lenses

A Double Masked, Randomised, Longitudinal Comparative Study to Evaluate the Wearability and Myopia Progression of ZEISS MyoCare Spectacle Lenses Versus Two ZEISS Single Vision Spectacle Lenses in Children With Myopia

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: ZEISS Vision Care · Industry
• Sex: All
• Age: 7 Years – 13 Years
• Healthy volunteers: Accepted

Summary

This is a clinical trial evaluating the wearability and effectiveness of three types of ZEISS spectacle lenses in controlling myopia progression. This study compares ZEISS MyoCare spectacle lenses with two types of single-vision spectacle lenses over a 6-month period. This trial aims to evaluate how well these lenses are worn and their impact on myopia progression, including changes in axial length and refractive error. Participants will be randomly assigned to wear one of three types of ZEISS spectacle lenses. The study will require five visits to the eye clinic over a 6-month period and two virtual follow-up visits.

Conditions

• Myopia

Interventions

Type	Name	Description
DEVICE	ZEISS MyoCare spectacle lenses	Spectacle lenses with conventional power profile including myopia control design.
DEVICE	ZEISS SV RX SPH 1.5	Commercially available single vision
DEVICE	ZEISS Clearview	Commercially available single vision

Timeline

• Start date: 2025-05-27
• Primary completion: 2026-01-01
• Completion: 2026-01-01
• First posted: 2025-06-15
• Last updated: 2025-06-15

Locations

1 site across 1 country: Vietnam